Paper Details

  1. Home
  2. Paper Details

Sulfasalazine for ankylosing spondylitis.

Author: ChenJunmin, LinShaopeng, LiuChao

Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Ankylosing spondylitis (AS) is a chronic inflammatory condition that primarily affects the spine and can limit movement. Sulfasalazine is a medication used to treat AS, but its effectiveness is uncertain. This review updates previous research on the use of sulfasalazine for AS.
Paper Details　
Original Abstract of the Article :
Ankylosing spondylitis (AS) is a chronic inflammatory disease of unknown cause and affects mainly the spine, but can also affect other joints. Disease progression may result in loss of mobility and function. Sulfasalazine is a disease-modifying antirheumatic drug used in the treatment of AS. However...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD004800.pub3

データ提供：米国国立医学図書館（NLM）

Sulfasalazine: A Potential Treatment for Ankylosing Spondylitis

This study delves into the world of [ankylosing spondylitis (AS) treatment], focusing on the effectiveness of sulfasalazine as a disease-modifying antirheumatic drug. This update of a Cochrane review aims to clarify the role of sulfasalazine in managing AS, a chronic inflammatory disease that primarily affects the spine.

Sulfasalazine's Efficacy in AS: A Need for More Evidence

The review acknowledges that while sulfasalazine is a commonly used treatment for AS, its efficacy remains [unclear]. The researchers highlight the need for more evidence to definitively determine its effectiveness in managing the disease. This is like searching for a specific type of oasis in a vast desert - finding the right treatment requires a thorough investigation.

Understanding Ankylosing Spondylitis

Ankylosing spondylitis (AS) can significantly impact a person's mobility and quality of life. This study emphasizes the importance of [continued research] to develop effective and safe treatments for this chronic condition. It's like searching for a hidden spring in a desolate desert - finding the right treatment can bring relief and improve the lives of those affected.

Dr.Camel's Conclusion

This review serves as a reminder that the search for effective treatments for chronic conditions like AS is an ongoing journey. The researchers' call for more evidence emphasizes the importance of [rigorous research and clinical trials] to ensure that patients receive the most effective care possible. It's like carefully mapping a vast and unfamiliar desert - understanding the intricacies of AS and finding the right treatments requires a dedicated effort to ensure the well-being of those affected.

Date :
  1. Date Completed 2014-12-30
  2. Date Revised 2022-03-21
Further Info :

Pubmed ID

25427435

DOI: Digital Object Identifier

10.1002/14651858.CD004800.pub3

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.